Salvador Ventura

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 68

Top Venues

Nature communications

Prion

Nucleic acids research

Journal of the American Chemical Society

Universitat Autònoma de Barcelona

Universitat Autónoma de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat Autònoma de Barcelona Jun 22 2011

Spain

Full Professor :: Dep. Biochemistry and Molecular Biology

Universitat Autònoma de Barcelona May 01 2005

Spain

Group Leader :: Institute of Biotechnology and Biomedicine

Universitat Autònoma de Barcelona Mar 01 2017 - Mar 10 2020

Spain

Director :: Institut de Biotecnologia i Biomedicina

Education History

Universitat Autónoma de Barcelona Jan 08 1994 - Sep 10 1998

Spain

PHD :: Dep. Biochemistry and Molecular Biology

Publications

Andrea Bartolomé-Nafría, Javier García-Pardo, Salvador Ventura
Mutations in human prion-like domains: pathogenic but not always amyloidogenic. Prion 18 (1) (2024)
Valentin Iglesias, Oriol Bárcenas, Carlos Pintado, Burdukiewicz Michał, Salvador Ventura
Structural information in therapeutic peptides: Emerging applications in biomedicine. FEBS open bio (2024)
Ariadna Fernández-Calvet, Leticia Matilla-Cuenca, Maria Izco, Susanna Navarro, Miriam Serrano, Salvador Ventura, Javier Blesa, Maite Herráiz, Gorka Alkorta-Aranburu, Sergio Galera, Ruiz De Los Mozos Igor, Maria Luisa Mansego, Alejandro Toledo-Arana, Lydia Alvarez-Erviti, Jaione Valle
Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration. Nature communications 15 (1) (2024)
Andrea Bartolomé-Nafría, Javier García-Pardo, Salvador Ventura
Mutations in human prion-like domains: pathogenic but not always amyloidogenic. Prion 18 (1) (2024)
Andrea Bartolomé-Nafría, Javier García-Pardo, Salvador Ventura
Mutations in human prion-like domains: pathogenic but not always amyloidogenic. Prion 18 (1) (2024)
Andrea Bartolomé-Nafría, Javier García-Pardo, Salvador Ventura
Mutations in human prion-like domains: pathogenic but not always amyloidogenic. Prion 18 (1) (2024)
Jaime Santos, Jorge Cuellar, Irantzu Pallarès, Emily J Byrd, Alons Lends, Fernando Moro, Muhammed Bilal Abdul-Shukkoor, Jordi Pujols, Lorea Velasco-Carneros, Frank Sobott, Daniel Erik Otzen, Antonio N Calabrese, Arturo Muga, Jan Skov Pedersen, Antoine Loquet, Jose María Valpuesta, Sheena E Radford, Salvador Ventura
A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion. Journal of the American Chemical Society 146 (18) (2024)
Jaime Santos, Jorge Cuellar, Irantzu Pallarès, Emily J Byrd, Alons Lends, Fernando Moro, Muhammed Bilal Abdul-Shukkoor, Jordi Pujols, Lorea Velasco-Carneros, Frank Sobott, Daniel Erik Otzen, Antonio N Calabrese, Arturo Muga, Jan Skov Pedersen, Antoine Loquet, Jose María Valpuesta, Sheena E Radford, Salvador Ventura
A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion. Journal of the American Chemical Society 146 (18) (2024)
Ariadna Fernández-Calvet, Leticia Matilla-Cuenca, Maria Izco, Susanna Navarro, Miriam Serrano, Salvador Ventura, Javier Blesa, Maite Herráiz, Gorka Alkorta-Aranburu, Sergio Galera, Ruiz De Los Mozos Igor, Maria Luisa Mansego, Alejandro Toledo-Arana, Lydia Alvarez-Erviti, Jaione Valle
Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration. Nature communications 15 (1) (2024)
Oriol Bárcenas, Aleksander Kuriata, Mateusz Zalewski, Valentin Iglesias, Carlos Pintado, Grzegorz Firlik, Burdukiewicz Michał, Sebastian Kmiecik, Salvador Ventura
Aggrescan4D: structure-informed analysis of pH-dependent protein aggregation. Nucleic acids research 52 (W1) (2024)
Jaime Santos, Jorge Cuellar, Irantzu Pallarès, Emily J Byrd, Alons Lends, Fernando Moro, Muhammed Bilal Abdul-Shukkoor, Jordi Pujols, Lorea Velasco-Carneros, Frank Sobott, Daniel Erik Otzen, Antonio N Calabrese, Arturo Muga, Jan Skov Pedersen, Antoine Loquet, Jose María Valpuesta, Sheena E Radford, Salvador Ventura
A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion. Journal of the American Chemical Society 146 (18) (2024)
Ariadna Fernández-Calvet, Leticia Matilla-Cuenca, Maria Izco, Susanna Navarro, Miriam Serrano, Salvador Ventura, Javier Blesa, Maite Herráiz, Gorka Alkorta-Aranburu, Sergio Galera, Ruiz De Los Mozos Igor, Maria Luisa Mansego, Alejandro Toledo-Arana, Lydia Alvarez-Erviti, Jaione Valle
Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration. Nature communications 15 (1) (2024)
Oriol Bárcenas, Aleksander Kuriata, Mateusz Zalewski, Valentin Iglesias, Carlos Pintado, Grzegorz Firlik, Burdukiewicz Michał, Sebastian Kmiecik, Salvador Ventura
Aggrescan4D: structure-informed analysis of pH-dependent protein aggregation. Nucleic acids research 52 (W1) (2024)
Oriol Bárcenas, Aleksander Kuriata, Mateusz Zalewski, Valentin Iglesias, Carlos Pintado, Grzegorz Firlik, Burdukiewicz Michał, Sebastian Kmiecik, Salvador Ventura
Aggrescan4D: structure-informed analysis of pH-dependent protein aggregation. Nucleic acids research (2024)
Oriol Bárcenas, Aleksander Kuriata, Mateusz Zalewski, Valentin Iglesias, Carlos Pintado, Grzegorz Firlik, Burdukiewicz Michał, Sebastian Kmiecik, Salvador Ventura
Aggrescan4D: structure-informed analysis of pH-dependent protein aggregation. Nucleic acids research 52 (W1) (2024)
Francisca Pinheiro, Salvador Ventura
Design and redesign journey of a drug for transthyretin amyloidosis. Neural regeneration research 20 (4) (2024)
Jaime Santos, Jorge Cuellar, Irantzu Pallarès, Emily J Byrd, Alons Lends, Fernando Moro, Muhammed Bilal Abdul-Shukkoor, Jordi Pujols, Lorea Velasco-Carneros, Frank Sobott, Daniel Erik Otzen, Antonio N Calabrese, Arturo Muga, Jan Skov Pedersen, Antoine Loquet, Jose María Valpuesta, Sheena E Radford, Salvador Ventura
A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion. Journal of the American Chemical Society (2024)
Jaime Santos, Jorge Cuellar, Irantzu Pallarès, Emily J Byrd, Alons Lends, Fernando Moro, Muhammed Bilal Abdul-Shukkoor, Jordi Pujols, Lorea Velasco-Carneros, Frank Sobott, Daniel Erik Otzen, Antonio N Calabrese, Arturo Muga, Jan Skov Pedersen, Antoine Loquet, Jose María Valpuesta, Sheena E Radford, Salvador Ventura
A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion. Journal of the American Chemical Society 146 (18) (2024)
Samuel Peña-Díaz, Javier García-Pardo, Salvador Ventura
Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson's Disease. Pharmaceutics 15 (3) (2023)
Aleksandra E Badaczewska-Dawid, Aleksander Kuriata, Carlos Pintado, Javier García-Pardo, Burdukiewicz Michał, Valentin Iglesias, Sebastian Kmiecik, Salvador Ventura
A3D Model Organism Database (A3D-MODB): a database for proteome aggregation predictions in model organisms. Nucleic acids research (2023)
Molood Behbahanipour, Roger M Benoit, Susanna Navarro, Salvador Ventura
OligoBinders: Bioengineered Soluble Amyloid-like Nanoparticles to Bind and Neutralize SARS-CoV-2. ACS applied materials & interfaces 15 (9) (2023)
Samuel Peña-Díaz, Javier García-Pardo, Salvador Ventura
Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson's Disease. Pharmaceutics 15 (3) (2023)
Javier García-Pardo, Andrea Bartolomé-Nafría, Antonio Chaves-Sanjuan, Marcos Gil-Garcia, Cristina Visentin, Martino Bolognesi, Stefano Ricagno, Salvador Ventura
Cryo-EM structure of hnRNPDL-2 fibrils, a functional amyloid associated with limb-girdle muscular dystrophy D3. Nature communications 14 (1) (2023)
Susanna Navarro, Marta Díaz-Caballero, Francesca Peccati, Lorena Roldán-Martín, Mariona Sodupe, Salvador Ventura
Amyloid Fibrils Formed by Short Prion-Inspired Peptides Are Metalloenzymes. ACS nano (2023)
Javier García-Pardo, Andrea Bartolomé-Nafría, Antonio Chaves-Sanjuan, Marcos Gil-Garcia, Cristina Visentin, Martino Bolognesi, Stefano Ricagno, Salvador Ventura
Cryo-EM structure of hnRNPDL-2 fibrils, a functional amyloid associated with limb-girdle muscular dystrophy D3. Nature communications 14 (1) (2023)
Molood Behbahanipour, Roger M Benoit, Susanna Navarro, Salvador Ventura
OligoBinders: Bioengineered Soluble Amyloid-like Nanoparticles to Bind and Neutralize SARS-CoV-2. ACS applied materials & interfaces 15 (9) (2023)
Carlos Pintado, Oriol Bárcenas, Valentin Iglesias, Jaime Santos, Zoe Manglano-Artuñedo, Irantzu Pallarès, Burdukiewicz Michał, Salvador Ventura
aSynPEP-DB: a database of biogenic peptides for inhibiting α-synuclein aggregation. Database : the journal of biological databases and curation 2023 (2023)
Javier García-Pardo, Salvador Ventura
Chemical targeting of amyloids. Nature chemical biology (2023)
Javier García-Pardo, Andrea Bartolomé-Nafría, Antonio Chaves-Sanjuan, Marcos Gil-Garcia, Cristina Visentin, Martino Bolognesi, Stefano Ricagno, Salvador Ventura
Cryo-EM structure of hnRNPDL-2 fibrils, a functional amyloid associated with limb-girdle muscular dystrophy D3. Nature communications 14 (1) (2023)
Javier García-Pardo, Andrea Bartolomé-Nafría, Antonio Chaves-Sanjuan, Marcos Gil-Garcia, Cristina Visentin, Martino Bolognesi, Stefano Ricagno, Salvador Ventura
Cryo-EM structure of hnRNPDL-2 fibrils, a functional amyloid associated with limb-girdle muscular dystrophy D3. Nature communications 14 (1) (2023)
Jaime Santos, Irantzu Pallarès, Salvador Ventura
A glimpse into the structural properties of α-synuclein oligomers. BioFactors (Oxford, England) (2023)
Molood Behbahanipour, Roger M Benoit, Susanna Navarro, Salvador Ventura
OligoBinders: Bioengineered Soluble Amyloid-like Nanoparticles to Bind and Neutralize SARS-CoV-2. ACS applied materials & interfaces 15 (9) (2023)
Javier García-Pardo, Andrea Bartolomé-Nafría, Antonio Chaves-Sanjuan, Marcos Gil-Garcia, Cristina Visentin, Martino Bolognesi, Stefano Ricagno, Salvador Ventura
Cryo-EM structure of hnRNPDL-2 fibrils, a functional amyloid associated with limb-girdle muscular dystrophy D3. Nature communications 14 (1) (2023)
Shaon Basu, Paula Martínez-Cristóbal, Marta Frigolé-Vivas, Mireia Pesarrodona, Michael Lewis, Elzbieta Szulc, C Adriana Bañuelos, Carolina Sánchez-Zarzalejo, Stasė Bielskutė, Jiaqi Zhu, Karina Pombo-García, Carla Garcia-Cabau, Levente Zodi, Hannes Dockx, Jordann Smak, Harpreet Kaur, Cristina Batlle, Borja Mateos, Mateusz Biesaga, Albert Escobedo, Lídia Bardia, Xavier Verdaguer, Alessandro Ruffoni, Nasrin R Mawji, Jun Wang, Jon K Obst, Teresa Tam, Isabelle Brun Heath, Salvador Ventura, David Meierhofer, Jesús García, Paul Robustelli, Travis H Stracker, Marianne D Sadar, Antoni Riera, Denes Hnisz, Xavier Salvatella
Rational optimization of a transcription factor activation domain inhibitor. Nature structural & molecular biology (2023)
Samuel Peña-Díaz, Javier García-Pardo, Salvador Ventura
Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson's Disease. Pharmaceutics 15 (3) (2023)
Molood Behbahanipour, Roger M Benoit, Susanna Navarro, Salvador Ventura
OligoBinders: Bioengineered Soluble Amyloid-like Nanoparticles to Bind and Neutralize SARS-CoV-2. ACS applied materials & interfaces 15 (9) (2023)
Nerea Ruiz-Solaní, Jose Salguero-Linares, Laia Armengot, Jaime Santos, Irantzu Pallarès, Katarina P van Midden, Ujjal J Phukkan, Seda Koyuncu, Júlia Borràs-Bisa, Liang Li, Ramona Mihaela Popa, Frederik Eisele, Anna Maria Eisele-Bürger, Sandra Malgrem Hill, Emilio Gutierrez-Beltran, Thomas Nyström, Marc Valls, Ernesto Llamas, David Vilchez, Marina Klemenčič, Salvador Ventura, Núria Sánchez Coll
Arabidopsis metacaspase MC1 localizes in stress granules, clears protein aggregates and delays senescence. The Plant cell (2023)
Carlos Pintado, Oriol Bárcenas, Salvador Ventura
In-Silico Analysis of pH-Dependent Liquid-Liquid Phase Separation in Intrinsically Disordered Proteins. Biomolecules 12 (7) (2022)
Francisca Pinheiro, Irantzu Pallarès, Francesca Peccati, Adrià Sánchez-Morales, Nathalia Varejão, Filipa Bezerra, David Ortega-Alarcon, Danilo Gonzalez, Marcelo Osorio, Susanna Navarro, Adrián Velázquez-Campoy, Maria Rosário Almeida, David Reverter, Félix Busqué, Ramon Alibés, Mariona Sodupe, Salvador Ventura
Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation. Journal of medicinal chemistry 65 (21) (2022)
Marcos Gil-Garcia, Valentin Iglesias, Irantzu Pallarès, Salvador Ventura
Prion-like proteins: from computational approaches to proteome-wide analysis. FEBS open bio 11 (9) (2021)
Weiqiang Wang, Marcos Gil-Garcia, Salvador Ventura
Dual Antibody-Conjugated Amyloid Nanorods to Promote Selective Cell-Cell Interactions. ACS applied materials & interfaces 13 (13) (2021)
Molood Behbahanipour, Javier García-Pardo, Salvador Ventura
Decoding the role of coiled-coil motifs in human prion-like proteins. Prion 15 (1) (2021)
Jaime Santos, Pablo Gracia, Susanna Navarro, Samuel Peña-Díaz, Jordi Pujols, Nunilo Cremades, Irantzu Pallarès, Salvador Ventura
α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity. Nature communications 12 (1) (2021)
Weiqiang Wang, Salvador Ventura
Prion domains as a driving force for the assembly of functional nanomaterials. Prion 14 (1) (2021)
Marta Díaz-Caballero, Susanna Navarro, Salvador Ventura
Functionalized Prion-Inspired Amyloids for Biosensor Applications. Biomacromolecules 22 (7) (2021)
Federica Quaglia, Bálint Mészáros, Edoardo Salladini, Andras Hatos, Rita Pancsa, Lucía Beatriz Chemes, Mátyás Pajkos, Tamas Lazar, Samuel Peña-Díaz, Jaime Santos, Veronika Ács, Nazanin Farahi, Erzsébet Fichó, Maria Cristina Aspromonte, Claudio Bassot, Anastasia Chasapi, Norman E Davey, Radoslav Davidović, László Dobson, Arne Elofsson, Gábor Erdős, Pascale Gaudet, Michelle G Giglio, Juliana Glavina, Javier Iserte, Valentin Iglesias, Zsófia Kálmán, Matteo Lambrughi, Emanuela Leonardi, Sonia Longhi, Sandra Macedo-Ribeiro, Emiliano Maiani, Julia Marchetti, Cristina Marino-Buslje, Attila Mészáros, Alexander Miguel Monzon, Giovanni Minervini, Suvarna Nadendla, Juliet F Nilsson, Marian Novotný, Christos A Ouzounis, Nicolas Palopoli, Elena Papaleo, Pedro José Barbosa Pereira, Gabriele Pozzati, Vasilis J Promponas, Jordi Pujols, Alma Carolina Sanchez Rocha, Martin Salas, Luciana Rodriguez Sawicki, Eva Schad, Aditi Shenoy, Tamás Szaniszló, Konstantinos D Tsirigos, Nevena Veljkovic, Gustavo Parisi, Salvador Ventura, Zsuzsanna Dosztányi, Peter Tompa, Silvio C E Tosatto, Damiano Piovesan
DisProt in 2022: improved quality and accessibility of protein intrinsic disorder annotation. Nucleic acids research (2021)
Ricardo Graña-Montes, Salvador Ventura
Reply to Comment on "N-terminal Protein Tail Acts as Aggregation Protective Entropic Bristles: The SUMO Case". Biomacromolecules 21 (8) (2020)
Jaime Santos, Valentin Iglesias, Carlos Pintado, Juan Santos-Suárez, Salvador Ventura
DispHred: A Server to Predict pH-Dependent Order-Disorder Transitions in Intrinsically Disordered Proteins. International journal of molecular sciences 21 (16) (2020)
Agustina Taglialegna, Leticia Matilla-Cuenca, Pedro Dorado-Morales, Susanna Navarro, Salvador Ventura, James A Garnett, Iñigo Lasa, Jaione Valle
The biofilm-associated surface protein Esp of Enterococcus faecalis forms amyloid-like fibers. NPJ biofilms and microbiomes 6 (1) (2020)
Francisca Pinheiro, Nathalia Varejão, Sebastian Esperante, Jaime Santos, Adrián Velázquez-Campoy, David Reverter, Irantzu Pallarès, Salvador Ventura
Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis. The FEBS journal 288 (1) (2020)
Eva Žerovnik, Salvador Ventura, Nataša Kopitar-Jerala
Special Issue: "Inflammation, Oxidative Stress and Protein Aggregation; Any Links?" Cells 9 (11) (2020)
Francesca Peccati, Marta Díaz-Caballero, Susanna Navarro, Luís Rodríguez-Santiago, Salvador Ventura, Mariona Sodupe
Atomistic fibrillar architectures of polar prion-inspired heptapeptides. Chemical science 11 (48) (2020)
Marta Díaz-Caballero, Susanna Navarro, Salvador Ventura
Soluble Assemblies in the Fibrillation Pathway of Prion-Inspired Artificial Functional Amyloids are Highly Cytotoxic. Biomacromolecules 21 (6) (2020)
Weiqiang Wang, Rafayel A Azizyan, Adriana Garro, Andrey V Kajava, Salvador Ventura
Multifunctional Amyloid Oligomeric Nanoparticles for Specific Cell Targeting and Drug Delivery. Biomacromolecules 21 (10) (2020)
Jaime Santos, Valentin Iglesias, Juan Santos-Suárez, Marco Mangiagalli, Stefania Brocca, Irantzu Pallarès, Salvador Ventura
pH-Dependent Aggregation in Intrinsically Disordered Proteins Is Determined by Charge and Lipophilicity. Cells 9 (1) (2020)
Marcos Gil-Garcia, Susanna Navarro, Salvador Ventura
Coiled-coil inspired functional inclusion bodies. Microbial cell factories 19 (1) (2020)
Valentin Iglesias, Oscar Conchillo-Sole, Cristina Batlle, Salvador Ventura
AMYCO: evaluation of mutational impact on prion-like proteins aggregation propensity. BMC bioinformatics 20 (1) (2019)
Weiqiang Wang, Susanna Navarro, Rafayel A Azizyan, Manuel Baño-Polo, Sebastian A Esperante, Andrey V Kajava, Salvador Ventura
Prion soft amyloid core driven self-assembly of globular proteins into bioactive nanofibrils. Nanoscale 11 (26) (2019)
Natalia Sanchez de Groot, Marc Torrent, Charles Nj Ravarani, Ala Trusina, Salvador Ventura, M Madan Babu
The fitness cost and benefit of phase-separated protein deposits. Molecular systems biology 15 (4) (2019)
Aleksandra Shcherbakova, Matthias Preller, Manuel H Taft, Jordi Pujols, Salvador Ventura, Birgit Tiemann, Falk F R Büttner, Hans Bakker
C-mannosylation supports folding and enhances stability of thrombospondin repeats. eLife 8 (2019)
Susanna Navarro, Salvador Ventura
Computational re-design of protein structures to improve solubility. Expert opinion on drug discovery 14 (10) (2019)
Marta Díaz-Caballero, Susanna Navarro, Isabel Fuentes, Francesc Teixidor, Salvador Ventura
Minimalist Prion-Inspired Polar Self-Assembling Peptides. ACS nano 12 (6) (2018)
Patrizia Marinelli, Susanna Navarro, Manuel Baño-Polo, Bertrand Morel, Ricardo Graña-Montes, Anna Sabe, Francesc Canals, Maria Rosario Fernandez, Francisco Conejero-Lara, Salvador Ventura
Global Protein Stabilization Does Not Suffice to Prevent Amyloid Fibril Formation. ACS chemical biology 13 (8) (2018)
Marta Díaz-Caballero, Maria Rosario Fernández, Susanna Navarro, Salvador Ventura
Prion-based nanomaterials and their emerging applications. Prion 12 (5-6) (2018)
Marcos Gil-Garcia, Manuel Bañó-Polo, Nathalia Varejão, Michal Jamroz, Aleksander Kuriata, Marta Díaz-Caballero, Jara Lascorz, Bertrand Morel, Susanna Navarro, David Reverter, Sebastian Kmiecik, Salvador Ventura
Combining Structural Aggregation Propensity and Stability Predictions To Redesign Protein Solubility. Molecular pharmaceutics 15 (9) (2018)
Hugo Fraga, Jordi Pujols, Marcos Gil-Garcia, Alicia Roque, Ganeko Bernardo-Seisdedos, Carlo Santambrogio, Joan-Josep Bech-Serra, Francesc Canals, Pau Bernadó, Rita Grandori, Oscar Millet, Salvador Ventura
Disulfide driven folding for a conditionally disordered protein. Scientific reports 7 (1) (2017)
Cristina Batlle, Natalia Sanchez de Groot, Valentin Iglesias, Susanna Navarro, Salvador Ventura
Characterization of Soft Amyloid Cores in Human Prion-Like Proteins. Scientific reports 7 (1) (2017)
Sebastián A Esperante, Giovanni Covaleda, Sebastián Alejandro Trejo, Sílvia Bronsoms, Francesc X Aviles, Salvador Ventura
Plasticity in the Oxidative Folding Pathway of the High Affinity Nerita Versicolor Carboxypeptidase Inhibitor (NvCI). Scientific reports 7 (1) (2017)

Salvador Ventura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Salvador Ventura